Gopalan Sethuraman

Title(s)Associate Professor of Research Neurology
AddressATR 9860 Mesa Rim Road
Off Campus
San Diego CA 92121
Phone+1 858 964 0794
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease. Stat Med. 2018 09 20; 37(21):3047-3055. Wang G, Berry S, Xiong C, Hassenstab J, Quintana M, McDade EM, Delmar P, Vestrucci M, Sethuraman G, Bateman RJ, Dominantly Inherited Alzheimer Network Trials Unit . PMID: 29761523.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    2. Representativeness of European clinical trial populations in mild Alzheimer's disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study. Alzheimers Res Ther. 2018 04 03; 10(1):36. Reed C, Belger M, Dell'Agnello G, Kahle-Wrobleski K, Sethuraman G, Hake A, Raskin J, Henley D. PMID: 29615123.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. Alzheimers Dement. 2016 Feb; 12(2):110-120. Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, Dowsett SA, Pontecorvo MJ, Dean RA, Demattos R. PMID: 26238576.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCTClinical Trials
    4. Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years. Alzheimers Dement (N Y). 2015 Sep; 1(2):111-121. Liu-Seifert H, Siemers E, Holdridge KC, Andersen SW, Lipkovich I, Carlson C, Sethuraman G, Hoog S, Hayduk R, Doody R, Aisen P. PMID: 29854931.
      View in: PubMed   Mentions:
    5. Peripheral and central effects of ?-secretase inhibition by semagacestat in Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):36. Doody RS, Raman R, Sperling RA, Seimers E, Sethuraman G, Mohs R, Farlow M, Iwatsubo T, Vellas B, Sun X, Ernstrom K, Thomas RG, Aisen PS, Alzheimer’s Disease Cooperative Study . PMID: 26064192.
      View in: PubMed   Mentions: 11     Fields:    
    6. Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings. Curr Med Res Opin. 2014 Oct; 30(10):2021-32. Henley DB, Sundell KL, Sethuraman G, Dowsett SA, May PC. PMID: 24983746.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    7. Adverse events and dropouts in Alzheimer's disease studies: what can we learn? Alzheimers Dement. 2015 Jan; 11(1):24-31. Henley DB, Sundell KL, Sethuraman G, Schneider LS. PMID: 24613705.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trial. J Biopharm Stat. 2014; 24(3):660-84. Habteab Ghebretinsae A, Molenberghs G, Dmitrienko A, Offen W, Sethuraman G. PMID: 24697817.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013 Jul 25; 369(4):341-50. Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG, Aisen PS, Alzheimer's Disease Cooperative Study Steering Committee , Siemers E, Sethuraman G, Mohs R, Semagacestat Study Group . PMID: 23883379.
      View in: PubMed   Mentions: 326     Fields:    Translation:HumansCTClinical Trials
    10. Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimers Dement. 2012 Jul; 8(4):261-71. Farlow M, Arnold SE, van Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER. PMID: 22672770.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCTClinical Trials
    11. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia. J Alzheimers Dis. 2012; 32(2):373-85. Yu P, Dean RA, Hall SD, Qi Y, Sethuraman G, Willis BA, Siemers ER, Martenyi F, Tauscher JT, Schwarz AJ. PMID: 22796873.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    12. Safety profile of Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative and other 18-month studies. Alzheimers Dement. 2012 Sep; 8(5):407-16. Henley DB, Sundell KL, Sethuraman G, Siemers ER, Alzheimer's Disease Neuroimaging Initiative . PMID: 22138370.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies. J Alzheimers Dis. 2011; 26(3):531-41. Lachno DR, Romeo MJ, Siemers ER, Vanderstichele H, Coart E, Konrad RJ, Zajac JJ, Talbot JA, Jensen HF, Sethuraman G, Demattos RB, May PC, Dean RA. PMID: 21694458.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    14. Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia. Am J Psychiatry. 2010 Feb; 167(2):181-9. Kane JM, Detke HC, Naber D, Sethuraman G, Lin DY, Bergstrom RF, McDonnell D. PMID: 20008947.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    15. In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. J Psychiatr Res. 2009 Jul; 43(11):997-1002. Reaven GM, Lieberman JA, Sethuraman G, Kraemer H, Davis JM, Blasey C, Tsuang MT, Schatzberg AF. PMID: 19268968.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    16. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes. Schizophr Res. 2006 Sep; 86(1-3):300-8. Dunayevich E, Sethuraman G, Enerson M, Taylor CC, Lin D. PMID: 16860974.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    17. Response to Kujawa et al. letter-to-the-editor. Schizophr Res. 2006 May; 84(1):172-3. Sethuraman G, Taylor CC, Enerson M, Dunayevich E. PMID: 16563702.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006 Mar; 59(3):490-8. Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR. PMID: 16453317.
      View in: PubMed   Mentions: 199     Fields:    Translation:Humans
    19. Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment? J Clin Psychopharmacol. 2006 Feb; 26(1):40-4. Beasley CM, Sutton VK, Taylor CC, Sethuraman G, Dossenbach M, Naber D. PMID: 16415704.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    20. Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype? J Affect Disord. 2005 Nov; 88(3):279-85. Barzman DH, McConville BJ, Masterson B, McElroy S, Sethuraman G, Moore K, Kahwaty AM, Nelson D. PMID: 16169087.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. The illusion of mental health: in the mind of which beholder? J Pers Assess. 2005 Aug; 85(1):92-7. Joiner TE, Brown JS, Perez M, Sethuraman G, Sallee FR. PMID: 16083388.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    22. A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. Schizophr Res. 2005 Nov 15; 79(2-3):337-40. Sethuraman G, Taylor CC, Enerson M, Dunayevich E. PMID: 16054802.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    23. The use of dietary supplements by veterans with cancer. J Altern Complement Med. 2004 Jun; 10(3):560-4. Jazieh AR, Kopp M, Foraida M, Ghouse M, Khalil M, Savidge M, Sethuraman G. PMID: 15253863.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    24. A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cogn Behav Neurol. 2004 Jun; 17(2):109-17. Chae JH, Nahas Z, Wassermann E, Li X, Sethuraman G, Gilbert D, Sallee FR, George MS. PMID: 15453520.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    25. Breast milk feeding rates of mothers of multiples compared to mothers of singletons. Ambul Pediatr. 2004 May-Jun; 4(3):226-31. Geraghty SR, Pinney SM, Sethuraman G, Roy-Chaudhury A, Kalkwarf HJ. PMID: 15153054.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov Disord. 2004 Apr; 19(4):416-25. Gilbert DL, Bansal AS, Sethuraman G, Sallee FR, Zhang J, Lipps T, Wassermann EM. PMID: 15077239.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    27. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry. 2004 Feb; 43(2):206-14. Gilbert DL, Batterson JR, Sethuraman G, Sallee FR. PMID: 14726728.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    28. Donors with central nervous system malignancies: are they truly safe? Transplantation. 2003 Jul 27; 76(2):340-3. Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, Alloway R, First MR, Woodle ES. PMID: 12883189.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    29. Psychosocial outcomes of a pilot multidisciplinary program for weight management. Am J Health Behav. 2003 Jul-Aug; 27(4):348-54. Brehm BJ, Rourke KM, Cassell C, Sethuraman G. PMID: 12882428.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry. 2003 Jun 01; 53(11):978-84. Kowatch RA, Sethuraman G, Hume JH, Kromelis M, Weinberg WA. PMID: 12788243.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    31. Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. Am J Clin Oncol. 2003 Apr; 26(2):174-7. Malik IA, Aziz Z, Zaidi SH, Sethuraman G. PMID: 12714891.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    32. Effect of weight change on bone mass in female adolescents. J Am Diet Assoc. 2003 Mar; 103(3):369-72. Rourke KM, Brehm BJ, Cassell C, Sethuraman G. PMID: 12616262.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Meta-analysis of EEG test performance shows wide variation among studies. Neurology. 2003 Feb 25; 60(4):564-70. Gilbert DL, Sethuraman G, Kotagal U, Buncher CR. PMID: 12601093.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    34. Neuroendocrine and behavioral responses to dopaminergic agonists in adolescents with alcohol abuse. Psychopharmacology (Berl). 2003 Mar; 166(2):95-101. Upadhyaya HP, Brady KT, Liao J, Sethuraman G, Middaugh L, Wharton M, Sallee FR. PMID: 12520313.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas. Am J Hematol. 2002 Jul; 70(3):181-5. Rohatgi N, LaRocca RV, Bard V, Sethuraman G, Foon KA. PMID: 12111762.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    36. Pulmonary cysts consistent with lymphangioleiomyomatosis are common in women with tuberous sclerosis: genetic and radiographic analysis. Chest. 2002 Mar; 121(3 Suppl):61S. McCormack F, Brody A, Meyer C, Leonard J, Chuck G, Dabora S, Sethuraman G, Colby TV, Kwiatkowski DJ, Franz DN. PMID: 11893688.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. Fenfluramine challenge in anxious children. Hum Psychopharmacol. 2000 Dec; 15(8):619-629. Sallee FR, Vrindavanam NS, Liu H, Sethuraman G, Sine L. PMID: 12404615.
      View in: PubMed   Mentions: 1     Fields:    
    Gopalan's Networks
    Concepts (224)
    Derived automatically from this person's publications.
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _